Furthermore, overexpression of miR-134 inhibited EGFR-related signaling and reduced NSCLC cell proliferation by inducing apoptosis and/or cell cycle arrest, inferring that miR-134 acts as an oncosuppressor in NSCLC. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.